Last edition
News about
Abbott Introduces FreeStyle Libre 2 Plus: Continuous Glucose Monitoring Without Fingersticks
Abbott, a global healthcare leader, has launched the FreeStyle Libre 2 Plus sensor in India, a device that delivers automatic glucose readings every minute directly to a user’s smartphone. The innovation aims to provide people living with diabetes greater confidence, precision, and ease in managing their condition.
Parexel Names Jim Anthony Chief Commercial Officer and President, Biotech Division
Parexel, a leading global clinical research organization (CRO), has appointed Jim Anthony as chief commercial officer (CCO) and president of Parexel Biotech, expanding his responsibilities to strengthen the company’s customer focus and accelerate growth.
Autonomix Secures New European Patent for Catheter-Based Technology
The newly issued ‘298 patent relates to the use of Autonomix’s proprietary technology to collect and process sensing data for real-time physiological monitoring.
ANGLE Forms Strategic Collaboration with Myriad Genetics
ANGLE plc has entered into a collaboration with Myriad Genetics to evaluate circulating tumour cell DNA using ANGLE’s Parsortix system alongside Myriad’s tissue-based assays, aiming to advance precision oncology.
Gilead's Kite Acquires Interius BioTherapeutics for USD 350 Million to Fuel In Vivo CAR-T Innovation
Gilead Sciences’ subsidiary Kite Pharma has announced the acquisition of Interius BioTherapeutics, a privately held biotech company, for USD 350 million in cash. The deal is aimed at advancing Kite’s development of in vivo CAR-T cell therapies, considered a next-generation approach to cancer treatment.
Stealth BioTherapeutics' Elamipretide NDA Resubmission Accepted for Review by US FDA
Stealth BioTherapeutics has announced that the US FDA has accepted for review its resubmitted New Drug Application for elamipretide to treat Barth syndrome, with a planned goal date of September 26, 2025.
PLI Scheme Brings Down Rare Disease Treatment Costs from Crores to Lakhs: Pharma Secretary
The Production Linked Incentive (PLI) Scheme for pharmaceuticals has significantly reduced the cost of treating rare diseases in India, bringing expenses down from crores to just a few lakhs, said Amit Agrawal, Secretary, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers.
Alvotech and Advanz Pharma Secure European Approval for Eylea Biosimilar Mynzepli
Alvotech and its commercial partner Advanz Pharma have announced that the European Commission has granted marketing authorisation for Mynzepli (aflibercept), a biosimilar to Eylea, available in both pre-filled syringes and vials.
Johnson and Johnson Commits USD 2 Billion to Expand US Manufacturing Amid Tariff Pressures
Johnson and Johnson has announced it will invest USD 2 billion in expanding its US manufacturing capacity over the next decade, responding to escalating concerns over trade and potential drug import tariffs.
Eli Lilly Announces Retirement of Anne White, Begins Search for Next Neuroscience Chief
Eli Lilly has announced that Anne White, Executive Vice President and President, Lilly Neuroscience, will retire from the company on December 31, 2025, after three decades of service.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy